In some individuals, tirzepatide reduces the desire for calorie dense foods more strongly than GLP-1 agents alone, which may explain the greater average weight loss seen in clinical studies
Albiglutide use in patients with HFrEF and diabetes was well tolerated, with subjects mainly reporting gastrointestinal events
We also now know that people on GLP-1s tend to be deficient in two specific micronutrients: vitamin D and vitamin B12, both of which affect energy, mood, and recovery
Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide
Does Medicaid cover Saxenda